NCT06948890

Brief Summary

This research is being performed to understand the role of music in people's opioid cravings, opioid use, and recovery. Music affects individuals in so many ways, and can trigger strong good and bad emotions. People listen when they are sad and want to feel happy, when they are with friends, when they exercise, and when they just want to pass the time. However, it is not known what role music plays in adding to or taking away cravings, and the role it has in drug use and addiction. In this study, the researchers want to learn if music can reduce cues that lead to cravings for opioids. The researchers also want to learn about subjects' relationship to music and how it contributes to drug use, recovery, and their life overall.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

April 20, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 29, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

March 4, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

April 20, 2025

Last Update Submit

March 3, 2026

Conditions

Keywords

opioidopioid use disordermethadonebuprenorphinemusiccue reactivity

Outcome Measures

Primary Outcomes (1)

  • Opioid Cravings

    Subjects will rank their craving for opioids on a 100-point Visual Analog Scale before and after being shown drug-related cues (images). The primary outcome will determine if there is a difference in craving levels in the music vs. silence groups.

    on Day 1

Study Arms (2)

music

EXPERIMENTAL

In this arm, subjects will rate their cravings for opioids on a 0-100 point visual analog scale. They will then listen to 2 songs of their choosing. They will then be shown a series of images "cues" related to drug use, and will again be asked their cravings for opioids.

Other: Music intervention

silence

PLACEBO COMPARATOR

In this arm, subjects will rate their cravings for opioids on a 0-100 point visual analog scale. They will then listen to 10 minutes of silence. They will then be shown a series of images "cues" related to drug use, and will again be asked their cravings for opioids.

Other: Silence

Interventions

Subjects will listen to two songs of their choosing. They will be prompted: "Please choose two songs that you really enjoy and that make you feel relaxed or take away stress".

music
SilenceOTHER

Subjects will listen to 10 minutes of silence through high quality noise canceling headphones

silence

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older
  • Current diagnosis of opioid use disorder
  • Actively receiving buprenorphine or methadone treatment with a stable dose of at least 30 days

You may not qualify if:

  • Any significant impairment in mental status that would interfere with the ability to provided informed consent including suicidality, homicidality, or psychosis.
  • Hearing impaired
  • Vision impaired
  • Patient reports that they are pregnant
  • Requiring the use of any prescription opioid analgesics during the trial
  • Currently prescribed naltrexone
  • Chronic pain, defined as pain on the numeric rating scale (0-10) of \>3 every day for over 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02459, United States

Location

Related Publications (5)

  • Suzuki J, Martin B, Prostko S, Chai PR, Weiss RD. Cannabidiol Effect on Cue-Induced Craving for Individuals with Opioid Use Disorder Treated with Buprenorphine: A Small Proof-of-Concept Open-Label Study. Integr Med Rep. 2022 Aug 1;1(1):157-163. doi: 10.1089/imr.2022.0070. Epub 2022 Aug 26.

    PMID: 36105269BACKGROUND
  • Chai PR, Carreiro S, Ranney ML, Karanam K, Ahtisaari M, Edwards R, Schreiber KL, Ben-Ghaly L, Erickson TB, Boyer EW. Music as an Adjunct to Opioid-Based Analgesia. J Med Toxicol. 2017 Sep;13(3):249-254. doi: 10.1007/s13181-017-0621-9. Epub 2017 Jun 23.

    PMID: 28646359BACKGROUND
  • Chai PR, Schreiber KL, Taylor SW, Jambaulikar GD, Kikut A, Hasdianda MA, Boyer EW. The Feasibility and Acceptability of a Smartphone-Based Music Intervention for Acute Pain. Proc Annu Hawaii Int Conf Syst Sci. 2019 Jan 8;2019:3917-3925.

    PMID: 30700971BACKGROUND
  • Chai PR, Schwartz E, Hasdianda MA, Azizoddin DR, Kikut A, Jambaulikar GD, Edwards RR, Boyer EW, Schreiber KL. A Brief Music App to Address Pain in the Emergency Department: Prospective Study. J Med Internet Res. 2020 May 20;22(5):e18537. doi: 10.2196/18537.

    PMID: 32432550BACKGROUND
  • Colebaugh CA, Wilson JM, Flowers KM, Overstreet D, Wang D, Edwards RR, Chai PR, Schreiber KL. The Impact of Varied Music Applications on Pain Perception and Situational Pain Catastrophizing. J Pain. 2023 Jul;24(7):1181-1192. doi: 10.1016/j.jpain.2023.01.006. Epub 2023 Jan 14.

    PMID: 36646399BACKGROUND

Related Links

MeSH Terms

Conditions

Opioid-Related Disorders

Interventions

SIR1 protein, S cerevisiae

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Scott G Weiner, MD, MPH

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 20, 2025

First Posted

April 29, 2025

Study Start

April 20, 2025

Primary Completion

August 28, 2025

Study Completion

February 28, 2026

Last Updated

March 4, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations